BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20956782)

  • 1. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.
    Zheng W; Wen W; Gao YT; Shyr Y; Zheng Y; Long J; Li G; Li C; Gu K; Cai Q; Shu XO; Lu W
    J Natl Cancer Inst; 2010 Jul; 102(13):972-81. PubMed ID: 20484103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating a breast cancer score in Spanish women. The MCC-Spain study.
    Dierssen-Sotos T; Gómez-Acebo I; Palazuelos C; Fernández-Navarro P; Altzibar JM; González-Donquiles C; Ardanaz E; Bustamante M; Alonso-Molero J; Vidal C; Bayo-Calero J; Tardón A; Salas D; Marcos-Gragera R; Moreno V; Rodriguez-Cundin P; Castaño-Vinyals G; Ederra M; Vilorio-Marqués L; Amiano P; Pérez-Gómez B; Aragonés N; Kogevinas M; Pollán M; Llorca J
    Sci Rep; 2018 Feb; 8(1):3036. PubMed ID: 29445177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
    Dite GS; MacInnis RJ; Bickerstaffe A; Dowty JG; Allman R; Apicella C; Milne RL; Tsimiklis H; Phillips KA; Giles GG; Terry MB; Southey MC; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):359-65. PubMed ID: 26677205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age.
    MacKarem G; Roche CA; Hughes KS
    Breast J; 2001; 7(1):34-9. PubMed ID: 11348413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    Allman R; Spaeth E; Lai J; Gross SJ; Hopper JL
    PLoS One; 2021; 16(1):e0245375. PubMed ID: 33481864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
    Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Rohan TE; Hankinson SE; Marcantonio ER; Ngo LH
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26625899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
    Tworoger SS; Zhang X; Eliassen AH; Qian J; Colditz GA; Willett WC; Rosner BA; Kraft P; Hankinson SE
    J Clin Oncol; 2014 Oct; 32(28):3111-7. PubMed ID: 25135988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.
    McCarthy AM; Armstrong K; Handorf E; Boghossian L; Jones M; Chen J; Demeter MB; McGuire E; Conant EF; Domchek SM
    Breast Cancer Res Treat; 2013 Apr; 138(3):889-98. PubMed ID: 23474973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.
    Gail MH
    J Natl Cancer Inst; 2009 Jul; 101(13):959-63. PubMed ID: 19535781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of breast cancer risk based on profiling with common genetic variants.
    Mavaddat N; Pharoah PD; Michailidou K; Tyrer J; Brook MN; Bolla MK; Wang Q; Dennis J; Dunning AM; Shah M; Luben R; Brown J; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Czene K; Darabi H; Eriksson M; Peto J; Dos-Santos-Silva I; Dudbridge F; Johnson N; Schmidt MK; Broeks A; Verhoef S; Rutgers EJ; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Figueroa J; Chanock SJ; Brinton L; Lissowska J; Couch FJ; Olson JE; Vachon C; Pankratz VS; Lambrechts D; Wildiers H; Van Ongeval C; van Limbergen E; Kristensen V; Grenaker Alnæs G; Nord S; Borresen-Dale AL; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Trentham-Dietz A; Newcomb P; Titus L; Egan KM; Hunter DJ; Lindstrom S; Tamimi RM; Kraft P; Rahman N; Turnbull C; Renwick A; Seal S; Li J; Liu J; Humphreys K; Benitez J; Pilar Zamora M; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Bogdanova NV; Antonenkova NN; Dörk T; Anton-Culver H; Neuhausen SL; Ziogas A; Bernstein L; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Cox A; Cross SS; Reed MW; Khusnutdinova E; Bermisheva M; Prokofyeva D; Takhirova Z; Meindl A; Schmutzler RK; Sutter C; Yang R; Schürmann P; Bremer M; Christiansen H; Park-Simon TW; Hillemanns P; Guénel P; Truong T; Menegaux F; Sanchez M; Radice P; Peterlongo P; Manoukian S; Pensotti V; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Brauch H; Brüning T; Ko YD; Sigurdson AJ; Doody MM; Hamann U; Torres D; Ulmer HU; Försti A; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Andrulis IL; Knight JA; Glendon G; Marie Mulligan A; Chenevix-Trench G; Balleine R; Giles GG; Milne RL; McLean C; Lindblom A; Margolin S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Eilber U; Wang-Gohrke S; Hooning MJ; Hollestelle A; van den Ouweland AM; Koppert LB; Carpenter J; Clarke C; Scott R; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Brenner H; Arndt V; Stegmaier C; Karina Dieffenbach A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Offit K; Vijai J; Robson M; Rau-Murthy R; Dwek M; Swann R; Annie Perkins K; Goldberg MS; Labrèche F; Dumont M; Eccles DM; Tapper WJ; Rafiq S; John EM; Whittemore AS; Slager S; Yannoukakos D; Toland AE; Yao S; Zheng W; Halverson SL; González-Neira A; Pita G; Rosario Alonso M; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; Simard J; Hall P; Easton DF; Garcia-Closas M
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.